Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon Alfa-2a Strategies in HBeAg-positive Chronic Hepatitis B
ChiCTR-OPC-17010647Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: HBsAg, HBV DNA and 3 more. Started Feb 2017; status: recruiting.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OPC-17010647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17010647.